1. 142: CONVERT – An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS). (January 2017) Authors: Faivre-Finn, C.; Snee, M.; Ashcroft, L.; Appel, W.; Barlesi, F.; Bhatnagar, A.; Bezjak, A.; Cardenal, F.; Fournel, P.; Harden, S.; Le Pechoux, C.; McMenemin, R.; Mohammed, N.; O'Brien, M.; Pantarotto, J.; Surmont, V.; Van Meerbeeck, J.; Woll, P.; Lorigan, P.; Blackhall, F. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. (May 2017) Authors: Sorber, L.; Zwaenepoel, K.; Deschoolmeester, V.; Van Schil, P.E.Y.; Van Meerbeeck, J.; Lardon, F.; Rolfo, C.; Pauwels, P. Journal: Lung cancer Issue: Volume 107(2017) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0503 Phase III trial of Prophylactic Cranial Irradiation with or without Hippocampus Avoidance in SCLC. (April 2019) Authors: Belderbos, J.; Phd, Md; De Ruysscher, D.; De Jaeger, K.; Koppe, F.; Lambrecht, M.; Lievens, Y.; Dieleman, E.; Jaspers, J.; Van Meerbeeck, J.; Ubbels, J.; Kwint, M.; Kuenen, M.; Deprez, S.; De Ruiter, M.; Sikorska, K.; Van Tinteren, H.; Schagen, S. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SP-0103: Better systemic therapy. (April 2016) Authors: Van Meerbeeck, J. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Survival outcomes in patients with advanced non‐small cell lung cancer treated with erlotinib: expanded access programme data from Belgium (the TRUST study). (24th October 2013) Authors: Van Meerbeeck, J.; Galdermans, D.; Bustin, F.; De Vos, L.; Lechat, I.; Abraham, I. Journal: European journal of cancer care Issue: Volume 23:Number 3(2014:May) Page Start: 370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗